New obesity combo drug tested for safety in japanese adults
NCT ID NCT06297616
First seen Jan 20, 2026 · Last updated Apr 29, 2026 · Updated 13 times
Summary
This study looked at the safety and side effects of a new drug called LY3841136, given alone or with another drug (tirzepatide), in 128 Japanese adults who are obese or overweight. Participants received multiple doses over several weeks, and researchers monitored for serious side effects and how the drugs affected body weight. The goal was to gather early safety data, not to cure obesity, so ongoing weight management would still be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hakata Clinic
Fukuoka, 812-0025, Japan
-
P-One Clinic
Hachiōji, Tokyo, 192-0071, Japan
-
Sumida Hospital
Sumida-ku, Tokyo, 130-0004, Japan
Conditions
Explore the condition pages connected to this study.